SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs

While Pneumocystis pneumonia (PcP) still impacts the AIDS patients, it has a growing importance in immunosuppressed HIV-negative patients. To determine the anti-Pneumocystis therapeutic efficacy of new compounds, animal and in vitro models have been developed. Indeed, well-designed mouse or rat expe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Standaert-Vitse, Annie, Aliouat-Denis, Cécile-Marie, Martinez, Anna, Khalife, Sara, Pottier, Muriel, Gantois, Nausicaa, Dei-Cas, Eduardo, Aliouat, El Moukhtar
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477875/
https://ncbi.nlm.nih.gov/pubmed/26103633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0130358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados